Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
International Journal of Pediatric Otorhinolaryngology
|
June 1, 1994
The effects of noise in transient EOAE newborn hearing screening
J T Jacobson, C A Jacobson
Journal of the American Academy of Audiology
|
October 1, 1990
Follow-up services in newborn hearing screening programs
C A Jacobson, J T Jacobson
Journal of the American Academy of Audiology
|
October 1, 1990
Automated and conventional ABR screening techniques in high-risk infants
J T Jacobson, C A Jacobson, R C Spahr
Ear and Hearing
|
June 1, 1989
Hearing loss in prison inmates
C A Jacobson, J T Jacobson, T A Crowe
Oncogene
|
May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G
G Posern, J Zheng, B S Knudsen, et al.
Nature Communications
|
February 12, 2022
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
I-M Launonen, N Lyytikäinen, J Casado, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
International Journal of Pediatric Otorhinolaryngology
|
June 1, 1994
The effects of noise in transient EOAE newborn hearing screening
J T Jacobson, C A Jacobson
Journal of the American Academy of Audiology
|
October 1, 1990
Follow-up services in newborn hearing screening programs
C A Jacobson, J T Jacobson
Journal of the American Academy of Audiology
|
October 1, 1990
Automated and conventional ABR screening techniques in high-risk infants
J T Jacobson, C A Jacobson, R C Spahr
Ear and Hearing
|
June 1, 1989
Hearing loss in prison inmates
C A Jacobson, J T Jacobson, T A Crowe
Oncogene
|
May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G
G Posern, J Zheng, B S Knudsen, et al.
Nature Communications
|
February 12, 2022
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
I-M Launonen, N Lyytikäinen, J Casado, et al.
Page
of 1